These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36901853)

  • 1. The PPAR-γ Agonist Pioglitazone Modulates Proliferation and Migration in HUVEC, HAOSMC and Human Arteriovenous Fistula-Derived Cells.
    Ciavarella C; Motta I; Vasuri F; Palumbo T; Lisi AP; Costa A; Astolfi A; Valente S; Versura P; Fornasiero EF; Mauro R; Gargiulo M; Pasquinelli G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia and hypoxia-inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula.
    Sadaghianloo N; Contenti J; Declemy S; Ambrosetti D; Zdralevic M; Tannour-Louet M; Fabbri L; Pagès G; Bost F; Hassen-Khodja R; Pouysségur J; Jean-Baptiste E; Dardik A; Mazure NM
    J Physiol; 2021 Apr; 599(8):2299-2321. PubMed ID: 33608879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heme Oxygenase 1/Peroxisome Proliferator-Activated Receptor Gamma Pathway Protects Intimal Hyperplasia and Mitigates Arteriovenous Fistula Dysfunction by Regulating Oxidative Stress and Inflammatory Response.
    Xie T; Xu Y; Ji L; Sui X; Zhang A; Zhang Y; Chen J
    Cardiovasc Ther; 2022; 2022():7576388. PubMed ID: 35812724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand Factor: A Central Regulator of Arteriovenous Fistula Maturation Through Smooth Muscle Cell Proliferation and Outward Remodeling.
    Laboyrie SL; de Vries MR; de Jong A; de Boer HC; Lalai RA; Martinez L; Vazquez-Padron RI; Rotmans JI
    J Am Heart Assoc; 2022 Aug; 11(16):e024581. PubMed ID: 35929448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
    Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is a key regulator of vascular smooth muscle cell proliferation in the outflow vein of arteriovenous fistulas.
    Ko DS; Baek SE; Ha M; Park JJ; Lee C; Kim HY; Jung Y; Kang JM; Kim YH
    Microvasc Res; 2023 Sep; 149():104570. PubMed ID: 37315777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-existing and Postoperative Intimal Hyperplasia and Arteriovenous Fistula Outcomes.
    Tabbara M; Duque JC; Martinez L; Escobar LA; Wu W; Pan Y; Fernandez N; Velazquez OC; Jaimes EA; Salman LH; Vazquez-Padron RI
    Am J Kidney Dis; 2016 Sep; 68(3):455-64. PubMed ID: 27012909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide-Binding Oligomerization Domain-Like Receptor Protein 3 Deficiency in Vascular Smooth Muscle Cells Prevents Arteriovenous Fistula Failure Despite Chronic Kidney Disease.
    Ding X; Chen J; Wu C; Wang G; Zhou C; Chen S; Wang K; Zhang A; Ye P; Wu J; Chen S; Zhang H; Xu K; Wang S; Xia J
    J Am Heart Assoc; 2019 Jan; 8(1):e011211. PubMed ID: 30587058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell activation by hemodynamic shear stress derived from arteriovenous fistula for hemodialysis access.
    Franzoni M; Cattaneo I; Longaretti L; Figliuzzi M; Ene-Iordache B; Remuzzi A
    Am J Physiol Heart Circ Physiol; 2016 Jan; 310(1):H49-59. PubMed ID: 26497959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomics of Human Arteriovenous Fistula Failure: Genes Associated With Nonmaturation.
    Martinez L; Tabbara M; Duque JC; Selman G; Falcon NS; Paez A; Griswold AJ; Ramos-Echazabal G; Hernandez DR; Velazquez OC; Salman LH; Vazquez-Padron RI
    Am J Kidney Dis; 2019 Jul; 74(1):73-81. PubMed ID: 30826088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intimal Hyperplasia and Arteriovenous Fistula Failure: Looking Beyond Size Differences.
    Vazquez-Padron RI; Duque JC; Tabbara M; Salman LH; Martinez L
    Kidney360; 2021 Aug; 2(8):1360-1372. PubMed ID: 34765989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
    Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
    EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients.
    Kim YO; Song HC; Yoon SA; Yang CW; Kim NI; Choi YJ; Lee EJ; Kim WY; Chang YS; Bang BK
    Am J Kidney Dis; 2003 Feb; 41(2):422-8. PubMed ID: 12552505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells.
    Desouza CV; Gerety M; Hamel FG
    Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients.
    Klotz L; Schmidt M; Giese T; Sastre M; Knolle P; Klockgether T; Heneka MT
    J Immunol; 2005 Oct; 175(8):4948-55. PubMed ID: 16210596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of pioglitazone on atrial structural and electrical remodeling in vitro cellular models.
    Gu J; Liu X; Wang QX; Guo M; Liu F; Song ZP; Zhang DD
    J Mol Cell Cardiol; 2013 Dec; 65():1-8. PubMed ID: 24100253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A; Wu L; Wang R; de Champlain J
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone inhibits TGFβ induced keratocyte transformation to myofibroblast and extracellular matrix production.
    Pan HW; Xu JT; Chen JS
    Mol Biol Rep; 2011 Oct; 38(7):4501-8. PubMed ID: 21127991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photochemical Tissue Passivation Attenuates AV Fistula Intimal Hyperplasia.
    Goldstone RN; McCormack MC; Goldstein RL; Mallidi S; Randolph MA; Watkins MT; Redmond RW; Austen WG
    Ann Surg; 2018 Jan; 267(1):183-188. PubMed ID: 27759615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
    Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
    Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.